Browse studies, page 1086

Page 1086 of 1,203, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Drug-drug interactions of empagliflozin and dapagliflozin European Heart Journal, 2024
• MO1034: Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Alport Syndrome and Fsgs: A Case Series Nephrology, Dialysis and Transplantation, 2022
• Theuse of LCZ-696(Sacubitril/Valsartan) and SGLT2inhibitors: A Real World Experience in a Rural African Patient with Heart Failure with Reduced Ejection Fraction (HFrEF). A Case Series Global Journal of Medical Research, 2023
• Metabolic and neuropathic outcomes following combined sodium-glucose cotransporter-2 inhibitor therapy and adjunctive acupuncture in obese patients with diabetic neuropathy: a case series Frontiers in Pain Research, 2026
• MON-587 SGLT2 Inhibitor-Related Starvation Ketoacidosis- a Case Series Journal of the Endocrine Society, 2025
• Comparative risk of cancer associated with SGLT inhibitors and DPP-4 inhibitors in patients with diabetes: a systematic review and meta-analysis Diabetology & metabolic syndrome, 2025
• Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Endocrinology, diabetes & metabolism, 2026
• SGLT2 inhibitors in cardiac amyloidosis: mechanistic insights and clinical perspectives-a narrative review Cardiovascular diabetology. Endocrinology reports, 2025
• Cardiotoxicity induced by multiple myeloma therapies: mechanistic convergence across proteasome inhibitors, CAR-T, and bispecific antibodies Blood cancer journal, 2026
• Unexpected Cancellation of Radioactive Iodine Treatment after Thyroid Hormone Withdrawal: Lessons from a Case Series Endocrinology and metabolism (Seoul, Korea), 2026
• Impact of Guideline-Directed Medical Therapy on Left Ventricular Function in Heart Failure Patients with Conventional Right Ventricular Pacing Journal of clinical medicine, 2026
• Baroreflex Activation Therapy in HFrEF Patients: Anti-Inflammatory Effects and Autonomic Restoration JACC. Case reports, 2026
• Facilitating Earlier Diagnosis of Pulmonary Hypertension Using a Novel Noninvasive Diagnostic JACC. Case reports, 2025
• Genotype-phenotype spectrum and clinical outcomes of glycogen storage disease type I: A 15-year experience at Vietnam National Children's Hospital Molecular genetics and metabolism reports, 2026
• Potential Role of SGLT-2 Inhibitors in Improving Allograft Function and Reducing Rejection in Kidney Transplantation Clinical transplantation, 2025
• Emerging therapeutic strategies for the failing Fontan circulation Annals of pediatric cardiology, 2026
• The Synergistic Treatment of Heart and Kidney Disease Deutsches Arzteblatt international, 2026
• The Role of Glucagon-like Peptide 1 Receptor Modulators for the Management of Dumping Syndrome in Patients Who have Undergone Metabolic and Bariatric Surgery: a Scoping Review Obesity surgery, 2026
• Catheter ablation of typical atrial flutter in a patient with left ventricular assist device support: a case report The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 2026
• Perioperative euglycemic DKA: The YIN and YANG of sodium-glucose cotransporter 2 inhibitors Journal of anaesthesiology, clinical pharmacology, 2025
• Emphysematous Cystitis in an Immunocompetent Patient on an SGLT2 Inhibitor Cureus, 2025
• Adult Annular Pancreas Presenting With Gastric Outlet Obstruction Following Semaglutide Initiation: A Case Report Cureus, 2026
• SGLT2 Inhibitors and the Risk of Arrhythmias in Heart Failure: A Network Meta-Analysis Journal of clinical medicine, 2025
• Use of acetazolamide in volume overload: start at the beginning Clinical kidney journal, 2026
• A pitfall in diagnosing type B insulin resistance syndrome: Suspected antibody interference in a patient with insulin allergy Journal of diabetes investigation, 2026
• Case Report: Oral semaglutide-associated depression in a patient with type 2 diabetes mellitus: a dose-dependent recurrence confirmed on rechallenge and managed with vortioxetine-bupropion combination therapy Frontiers in psychiatry, 2026
• Temporary Left Ventricular Assist Device for Peripartum Cardiogenic Shock as a Bridge to Cesarean Delivery JACC. Case reports, 2026
• Identification of Endogenous Hypercortisolism and the Effect of Mifepristone Treatment in Patients With Difficult-to-Manage Diabetes: A Case Series Diabetes spectrum : a publication of the American Diabetes Association, 2025
• Role of Venoarterial Extracorporeal Membrane Oxygenation as a Procedural Support Tool in Cardiovascular Instability: A Case Series Case reports in cardiology, 2025
• Secretagogue laxatives as a potential strategy to overcome adherence barriers to over-the-counter treatment for clozapine-induced constipation The mental health clinician, 2026
• A case of perioperative euglycemic ketoacidosis in a patient without diabetes: are current guidelines enough? Perioperative medicine (London, England), 2025
• Comparative Effectiveness of SGLT2 Inhibitors and Semaglutide in Diabetic Nephropathy: A Retrospective Observational Study Cureus, 2025
• The dual role of SGLT2 inhibitors: glycemic control and cardioprotection in anthracycline-treated cancer patients International journal of physiology, pathophysiology and pharmacology, 2025
• The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance Pediatric diabetes, 2025
• A Comparative Analysis of Diabetic Ketoacidosis (DKA) in Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Users Versus Non-users: A Systematic Review Cureus, 2025
• Linagliptin-Induced Bullous Pemphigoid: A Case Report and Comprehensive Literature Review Cureus, 2025
• Recognizing and Mitigating the Effects of Medication on Heat-Related Illness in Older Adults: A Scoping Review Pharmacy (Basel, Switzerland), 2026
• Role of sodium-glucose cotransporter 2 inhibitors in liver diseases World journal of experimental medicine, 2025
• Pregnancy Outcomes Following Maternal Fenofibrate Exposure Congenital anomalies, 2026
• The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management Frontiers in endocrinology, 2026
• The Potential Role of SGLT2 Inhibitors in Cushing's Disease Diabetes, obesity & metabolism, 2026
• Severe Euglycemic Diabetic Ketoacidosis Requiring Intubation After Tirzepatide and SGLT2 Inhibitor Coadministration in a Patient With Type 1 Diabetes Mellitus From a Large Tertiary Care Centre in Karachi, Pakistan: A Case Report and Brief Review of the Literature Clinical case reports, 2026
• New hope for young hearts: A systematic review of sodium glucose cotransporter 2 inhibitors in pediatric heart failure Annals of pediatric cardiology, 2025
• Refractory Heart Failure in Noncompaction Cardiomyopathy Despite Guideline-Directed Therapy: A Case Series Cureus, 2026
• Sodium-Glucose Cotransporter 2 Inhibitors in Underweight Patients with Heart Failure: A Case Series Journal of clinical medicine, 2026
• SGLT-2 inhibitors in prevention of chemotherapy-induced cardiotoxicity: systematic review and meta-analysis European heart journal open, 2026
• Empagliflozin as treatment in glycogen storage disease type IB patients Molecular genetics and metabolism reports, 2025
• Active Safety Surveillance Using Real-World Evidence (ASSURE) Implementation: Transparent and Reproducible Real-World Evidence Standardized Framework to Support Safety Signal Evaluation Pharmacoepidemiology and drug safety, 2026
• SGLT2 inhibition for patients with ADPKD - closing the evidence gap Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025
• Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol JMIR research protocols, 2026
• Sodium-Glucose Cotransporter-2 Inhibitors and Euglycemic Diabetic Ketoacidosis: A Case Series of Three Post-surgical Patients Cureus, 2025
• Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India Cureus, 2026
• SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series Case reports in nephrology, 2025
• Real-world presentation of myocardial bridging in the cath-lab: a case series European heart journal. Case reports, 2026
• Expanding the Therapeutic Landscape: Sodium-Glucose Co-transporter 2 Inhibitors in Kidney Transplant Recipients Cureus, 2025
• SGLT2 Inhibitors and Liver Cirrhosis: Hype or Hope? Life (Basel, Switzerland), 2025
• Early In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors After ST-Elevation Myocardial Infarction: A Clinical Review of Hemodynamic and Renal Safety Reviews in cardiovascular medicine, 2026
• Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Cisplatin Nephrotoxicity: A Mechanistic Review Kidney360, 2026
• SGLT-2 inhibitor-associated significant hypernatremia and euglycemic diabetic ketoacidosis after cardiac surgery: a case series Journal of cardiothoracic surgery, 2026
• SGLT2 inhibitor therapy in overweight and obese patients with cystic fibrosis-related diabetes: Case series Journal of clinical & translational endocrinology, 2025
• Clinical Outcomes and Management in Late Diagnosed Siblings Affected With Attenuated GSD Ib JIMD reports, 2026
• Repurposing SGLT2 Inhibitors for Cirrhotic Ascites: From Mechanistic Research to Clinical Exploration Journal of clinical and translational hepatology, 2026
• Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies Endocrine connections, 2026
• Midodrine to facilitate cardioprotective therapy in hypotensive HER2-positive breast cancer patients with cancer-therapy-related cardiac dysfunction-multicenter case experience Cardio-oncology (London, England), 2026
• SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis Cureus, 2026
• Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series Reviews on recent clinical trials, 2018
• Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series ESC heart failure, 2020
• Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Associated Diabetic Ketoacidosis in Oncology Patients: A Case Series and Literature Review Cureus, 2024
• Sodium-glucose cotransporter 2 inhibitors reduce albuminuria in patients with Fabry disease: a real-world case series Internal medicine journal, 2025
• Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports World journal of diabetes, 2023
• Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2022
• SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series Advances in hematology, 2025
• Tizanidine Withdrawal Syndrome: Clinical Manifestations and Management Strategies. Case Series Journal of pain & palliative care pharmacotherapy, 2026
• A Case Series of SGLT2i Improving Hemoglobin in Adults with Myelodysplastic Syndrome Acta haematologica, 2025
• A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care Diabetes & metabolic syndrome, 2022
• Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview of Its Chemistry, Pharmacology, and Toxicology Current diabetes reviews, 2024
• Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult The American journal of medicine, 2020
• Adverse events and drug-drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure Expert review of cardiovascular therapy, 2023
• Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis Expert opinion on drug safety, 2025
• Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus Kidney & blood pressure research, 2019
• Severe Vulvovaginal Candidiasis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Use in Postmenopausal Women Journal of lower genital tract disease, 2024
• Stroke Risk Following Takotsubo Cardiomyopathy The Neurohospitalist, 2020
• Factors influencing the professional identity of nursing interns: a cross-sectional study BMC Nursing, 2022
• Indexes of ferroptosis and iron metabolism were associated with the severity of diabetic nephropathy in patients with type 2 diabetes mellitus: a cross-sectional study Frontiers in Endocrinology, 2023
• Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic Heliyon, 2023
• Serum per- and polyfluoroalkyl substances and abnormal lipid metabolism: A nationally representative cross-sectional study Environment International, 2023
• The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator Cardiovascular Diabetology, 2024
• Medical Student Experiences and Perceptions of ChatGPT and Artificial Intelligence: Cross-Sectional Study JMIR Medical Education, 2023
• Prevalence of Genitourinary Infections with Sodium Glucose Co-transporter-2 (sglt2) inhibitors in patients with type 2 diabetes Pakistan Journal of Medical & Health Sciences, 2021
• Occurence of urinary tract infections in type 2 diabetes mellitus patients taking sodium-glucose co-transporter-2 (SGLT-2) inhibitors to regulate their blood sugar levels International Journal of Health Sciences, 2023
• In Reply to “Letter Regarding ‘Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis’” Kidney International Reports, 2023
• Need of the hour: pharmacovigilance study of SGLT-2 inhibitors International Journal of Research in Medical Sciences, 2019
• Nationwide Trends in Dispensing of Sodium Glucose Cotransporter 2 Inhibitors The Canadian Journal of Hospital Pharmacy, 2022
• Sodium/Glucose Cotransporter 2 Inhibition and Urolithiasis: The Effect of Urinary pH and Citrate Kidney International Reports, 2023
• A64-08 Metabolic Reprogramming in Pulmonary Vascular Disease: Insights From Sglt2 Inhibitor Therapy American Journal of Respiratory and Critical Care Medicine, 2026
• A comparative assessment of TWO antidiabetic medication on glucose level lipid profile and CBC in a RAT model with type II diabetes mellitus Journal of Medical Genetics and Clinical Biology, 2026
• Physicians Experience with SGLT- 2 Inhibitors In Type 2 Diabetic Patients Annals of King Edward Medical University, 2025
• Effects of SGLT2 Inhibitors on Circulating Cyclophilin A Levels in Patients with Type 2 Diabetes Current Medicinal Chemistry, 2025
• Cutting costs, not quality: A cost minimization analysis of diabetes care at Northwest General Hospital and Research Center The Professional Medical Journal, 2026
• Full tablet and half tablet empagliflozin prescription demographic and glycemic control Journal of the ASEAN Federation of Endocrine Societies, 2023